These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 34641629)

  • 1. Cudraxanthone D Ameliorates Psoriasis-like Skin Inflammation in an Imiquimod-Induced Mouse Model via Inhibiting the Inflammatory Signaling Pathways.
    Kim N; Lee S; Kang J; Choi YA; Jang YH; Jeong GS; Kim SH
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gomisin M2 alleviates psoriasis‑like skin inflammation by inhibiting inflammatory signaling pathways.
    Kim N; Lee S; Kang J; Kwon TK; Khang D; Kim SH
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34664681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hispidulin alleviates imiquimod-induced psoriasis-like skin inflammation by inhibiting splenic Th1/Th17 cell population and keratinocyte activation.
    Kim N; Lee S; Kang J; Choi YA; Lee B; Kwon TK; Jang YH; Kim SH
    Int Immunopharmacol; 2020 Oct; 87():106767. PubMed ID: 32679548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astragaloside IV suppresses the proliferation and inflammatory response of human epidermal keratinocytes and ameliorates imiquimod-induced psoriasis-like skin damage in mice.
    Liu T; Ai L; Jiang A; Wang Y; Jiang R; Liu L
    Allergol Immunopathol (Madr); 2024; 52(5):44-50. PubMed ID: 39278850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice.
    Gao J; Chen F; Fang H; Mi J; Qi Q; Yang M
    Biol Res; 2020 Oct; 53(1):48. PubMed ID: 33081840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Topical Application of Betamethasone on Imiquimod-induced Psoriasis-like Skin Inflammation in Mice.
    Mori H; Arita K; Yamaguchi T; Hirai M; Kurebayashi Y
    Kobe J Med Sci; 2016 Sep; 62(4):E79-E88. PubMed ID: 28239073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protectin D1 reduces imiquimod-induced psoriasiform skin inflammation.
    Park KD; Kim N; Kang J; Dhakal H; Kim JY; Jang YH; Lee WJ; Lee SJ; Kim SH
    Int Immunopharmacol; 2021 Sep; 98():107883. PubMed ID: 34153674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical administration of reversible SAHH inhibitor ameliorates imiquimod-induced psoriasis-like skin lesions in mice via suppression of TNF-α/IFN-γ-induced inflammatory response in keratinocytes and T cell-derived IL-17.
    Lin ZM; Ma M; Li H; Qi Q; Liu YT; Yan YX; Shen YF; Yang XQ; Zhu FH; He SJ; Tang W; Zuo JP
    Pharmacol Res; 2018 Mar; 129():443-452. PubMed ID: 29155016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cimifugin ameliorates imiquimod-induced psoriasis by inhibiting oxidative stress and inflammation via NF-κB/MAPK pathway.
    Liu A; Zhao W; Zhang B; Tu Y; Wang Q; Li J
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway.
    Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P
    Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycyrrhizin ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice and inhibits TNF-α-induced ICAM-1 expression via NF-κB/MAPK in HaCaT cells.
    Xiong H; Xu Y; Tan G; Han Y; Tang Z; Xu W; Zeng F; Guo Q
    Cell Physiol Biochem; 2015; 35(4):1335-46. PubMed ID: 25720416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
    Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
    Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Yang BY; Cheng YG; Liu Y; Liu Y; Tan JY; Guan W; Guo S; Kuang HX
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31181689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dang-Gui-Liu-Huang Tang a traditional herbal formula, ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by inhibiting IL-22 production.
    Nguyen LTH; Ahn SH; Nguyen UT; Yang IJ
    Phytomedicine; 2018 Aug; 47():48-57. PubMed ID: 30166108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genistein suppresses psoriasis-related inflammation through a STAT3-NF-κB-dependent mechanism in keratinocytes.
    Wang A; Wei J; Lu C; Chen H; Zhong X; Lu Y; Li L; Huang H; Dai Z; Han L
    Int Immunopharmacol; 2019 Apr; 69():270-278. PubMed ID: 30743203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amentoflavone protects against psoriasis-like skin lesion through suppression of NF-κB-mediated inflammation and keratinocyte proliferation.
    An J; Li Z; Dong Y; Ren J; Huo J
    Mol Cell Biochem; 2016 Feb; 413(1-2):87-95. PubMed ID: 26724949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperforin Ameliorates Imiquimod-Induced Psoriasis-Like Murine Skin Inflammation by Modulating IL-17A-Producing γδ T Cells.
    Zhang S; Zhang J; Yu J; Chen X; Zhang F; Wei W; Zhang L; Chen W; Lin N; Wu Y
    Front Immunol; 2021; 12():635076. PubMed ID: 34025642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The small molecule rhodomyrtone suppresses TNF-α and IL-17A-induced keratinocyte inflammatory responses: A potential new therapeutic for psoriasis.
    Chorachoo J; Lambert S; Furnholm T; Roberts L; Reingold L; Auepemkiate S; Voravuthikunchai SP; Johnston A
    PLoS One; 2018; 13(10):e0205340. PubMed ID: 30321197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral administration of punicalagin attenuates imiquimod-induced psoriasis by reducing ROS generation and inflammation via MAPK/ERK and NF-κB signaling pathways.
    Wang Y; Han D; Huang Y; Dai Y; Wang Y; Liu M; Wang N; Yin T; Du W; He K; Zheng Y
    Phytother Res; 2024 Feb; 38(2):713-726. PubMed ID: 38009260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-27 activates Th1-mediated responses in imiquimod-induced psoriasis-like skin lesions.
    Shibata S; Tada Y; Asano Y; Yanaba K; Sugaya M; Kadono T; Kanda N; Watanabe S; Sato S
    J Invest Dermatol; 2013 Feb; 133(2):479-88. PubMed ID: 22951728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.